ClinicalTrials.govpublic full text
A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.
philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp), adult, chronic myelogenous leukemia (cml), chronic myeloid leukemia (cml), chronic myelocytic leukemia (cml), acute lymphoblastic leukemia (all) philadelphia chromosome positive, acute lymphoid leukemia, suboptimal molecular response, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 993650
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.